Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018)
Sintx Technologies (SINT) posted Cash from Discontinued Operations of $882000.0 for Q4 2018, up 352.31% on a QoQ basis from $195000.0 in Q3 2018, and down 47.84% year-over-year from $1.7 million in Q4 2017.
Powered by 
Analysis
Sintx Technologies (SINT) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends
Sintx Technologies has reported Cash from Discontinued Operations for 2 years, with the latest figure at $882000.0 in Q4 2018.
- On a quarterly basis, Cash from Discontinued Operations fell 47.84% year-over-year to $882000.0 in Q4 2018; TTM through Dec 2018 was $675000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $675000.0, down 72.42% from the prior year.
- Cash from Discontinued Operations was $882000.0 for Q4 2018 at Sintx Technologies, up from $195000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was $1.7 million in Q4 2017, with the low at -$616000.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 882,000.00 |
| Sep 30, 2018 | 195,000.00 |
| Jun 30, 2018 | -616,000.00 |
| Mar 31, 2018 | 214,000.00 |
| Dec 31, 2017 | 1.69 Mn |